Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Evaluation Study for Patients With Polycythemia Vera
- First Posted Date
- 2021-10-12
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Perseus Proteomics Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05074550
- Locations
- 🇯🇵
Kansai Medical University Hospital, Hirakata, Osaka, Japan
🇯🇵Shimane University Hospital, Izumo, Shimane, Japan
🇯🇵Osaka City University Hospital, Osaka, Japan
News
No news found